A Copper‐Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti‐Tumor Immune Responses
Small · 2025
DOI: 10.1002/smll.202412174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Luoyingzi Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, P. R. China. Hauptthemen laut MEDLINE: Copper, Nanocomposites, Manganese, Immunity. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Health Commission, Chongqing Human Resources and Social Security Bureau.
Abstract (Originalsprache)
Cancer is one of the most important challenges worldwide with an increasing incidence. However, most of patients with malignant cancer receiving traditional therapies have tumor recurrence and short‐term 5‐year survival. Herein, a novel Cu 2 O‐MnO@PEG (CMP) nanomaterial is developed to treat tumors. CMP directly mediates cuproptosis in tumor cells. Meanwhile, CMP potentiates anti‐tumor immune responses in the tumor microenvironment (TME) to induce tumor regression. CMP improves the tumor antigen processing and presentation of dendritic cells and tumor‐associated macrophages, and further promotes CD8 + T cell responses, especially for cytotoxic CD8 + T cells and transitory exhausted CD8 + T cells. Additionally, CMP downregulates the proportion of Treg cells and CTLA‐4 expression on Treg cells. Notably, CMP induces systemic immune responses against distant tumors and long‐term immune memory. Furthermore, CMP synergized with PD‐L1 mAb promotes tumor inhibition and sustains the anti‐tumor efficacy post PD‐L1 mAb treatment. Collectively, this strategy has the clinically therapeutic potential for tumors by facilitating cuproptosis in tumor cells and anti‐tumor immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, P. R. China.
- Chongqing Key Laboratory of Intelligent Medicine Engineering for Hepatopancreatobiliary Diseases, Chongqing, 401147, P. R. China.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, P. R. China.
- School of Clinical Medicine, Chongqing Medical University, Chongqing, 400016, P. R. China.
- Department of Hepatobiliary Surgery, Leshan People's Hospital, Leshan, 614000, P. R. China.
- Department of Dermatology, Southwest Hospital Jiangbei Area (The 958th hospital of Chinese People's Liberation Army), Chongqing, 400020, P. R. China.
ORCID-Profile: Huaizhi Wang
Förderung
- National Natural Science Foundation of China
- Chongqing Municipal Health Commission
- Chongqing Human Resources and Social Security Bureau
- Southwest Hospital Jiangbei Area (The 958th hospital of Chinese People's Liberation Army)
- Chongqing Municipal Human Resources and Social Security Bureau
Zitieren
APA
Xie, L., Gong, J., He, Z., Zhang, W., Wang, H., Wu, S., Wang, X., Sun, P., Cai, L., Wu, Z., & Wang, H. (2025). A Copper‐Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti‐Tumor Immune Responses. Small. https://doi.org/10.1002/smll.202412174
Vancouver
Xie L, Gong J, He Z, Zhang W, Wang H, Wu S, et al. A Copper‐Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti‐Tumor Immune Responses. Small. 2025. doi:10.1002/smll.202412174
BibTeX
@article{Xie2025,
author = {Xie, Luoyingzi and Gong, Jie and He, Zhiqiang and Zhang, Weinan and Wang, Haoyu and Wu, Shitao and Wang, Xianxing and Sun, Pijiang and Cai, Lei and Wu, Zhongjun and Wang, Huaizhi},
title = {A Copper‐Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti‐Tumor Immune Responses},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202412174}
}
EUVIMED